Ocular Therapeutix, Inc. (OCUL)

NASDAQ: OCUL · IEX Real-Time Price · USD

6.68

+0.02 (0.30%)

At close: Jul 2, 2024, 4:00 PM

6.60

-0.08 (-1.20%)

After-hours: Jul 2, 2024, 7:42 PM EDT

Ocular Therapeutix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-80.74	-71.04	-6.55	-155.64	-86.37	Upgrade
Depreciation & Amortization	2.98	2.11	2.42	2.77	2.53	Upgrade
Share-Based Compensation	17.83	16.96	14.98	7.53	8.76	Upgrade
Other Operating Activities	-10.31	-7.64	-76.4	91.78	-2.5	Upgrade
Operating Cash Flow	-70.23	-59.6	-65.55	-53.55	-77.58	Upgrade
Capital Expenditures	-6.09	-3.72	-1.19	-0.84	-2.24	Upgrade
Investing Cash Flow	-6.09	-3.72	-1.19	-0.84	-2.24	Upgrade
Share Issuance / Repurchase	118.66	1.45	3.57	228.01	38.07	Upgrade
Debt Issued / Paid	51.17	0	-0.45	0	37.28	Upgrade
Other Financing Activities	-	-	-0.28	-	-	Upgrade
Financing Cash Flow	169.83	1.45	2.85	228.01	75.34	Upgrade
Net Cash Flow	93.51	-61.86	-63.89	173.62	-4.48	Upgrade
Free Cash Flow	-76.32	-63.32	-66.74	-54.4	-79.82	Upgrade
Free Cash Flow Margin	-130.59%	-122.96%	-153.36%	-312.56%	-1888.24%	Upgrade
Free Cash Flow Per Share	-0.96	-0.82	-0.87	-0.90	-1.76	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).